| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.09 |